2012 annual financial data
Vertex Pharmaceuticals 2012 Operating cash flow growth
Direct answer
Operating cash flow growth was 86.34%.
Operating income was 2,332,000 USD and net income was -107,032,000 USD.
Operating cash flow was 267,841,000 USD.
Get free Vertex Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,527,042,000 USD
- Operating income
- 2,332,000 USD
- Net income
- -107,032,000 USD
- Operating cash flow
- 267,841,000 USD